150 related articles for article (PubMed ID: 28730380)
1. Acute and Chronic Effects of Oral Erdosteine on Ciliary Beat Frequency, Cough Sensitivity and Airway Reactivity.
Pappová L; Kazimierová I; Jošková M; Šutovská M; Fraňová S
Adv Exp Med Biol; 2018; 1023():1-10. PubMed ID: 28730380
[TBL] [Abstract][Full Text] [Related]
2. The effect of erdosteine on airway defence mechanisms and inflammatory cytokines in the settings of allergic inflammation.
Fraňová S; Kazimierová I; Pappová L; Molitorisová M; Jošková M; Šutovská M
Pulm Pharmacol Ther; 2019 Feb; 54():60-67. PubMed ID: 30502381
[TBL] [Abstract][Full Text] [Related]
3. Mucolytic and antitussive effects of erdosteine.
Hosoe H; Kaise T; Ohmori K; Isohama Y; Kai H; Takahama K; Miyata T
J Pharm Pharmacol; 1999 Aug; 51(8):959-66. PubMed ID: 10504037
[TBL] [Abstract][Full Text] [Related]
4. Erdosteine: antitussive and anti-inflammatory effects.
Dal Negro RW
Lung; 2008; 186 Suppl 1():S70-3. PubMed ID: 18185958
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the cough reflex and airway reactivity in toluene- and ovalbumin-induced airway hyperresponsiveness.
Mokry J; Nosalova G
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):419-26. PubMed ID: 18204154
[TBL] [Abstract][Full Text] [Related]
6. The anti-asthmatic potential of flavonol kaempferol in an experimental model of allergic airway inflammation.
Molitorisova M; Sutovska M; Kazimierova I; Barborikova J; Joskova M; Novakova E; Franova S
Eur J Pharmacol; 2021 Jan; 891():173698. PubMed ID: 33129789
[TBL] [Abstract][Full Text] [Related]
7. A controlled multicenter pediatric study in the treatment of acute respiratory tract diseases with the aid of a new specific compound, erdosteine (IPSE, Italian Pediatric Study Erdosteine).
Titti G; Lizzio A; Termini C; Negri P; Fazzio S; Mancini C
Int J Clin Pharmacol Ther; 2000 Aug; 38(8):402-7. PubMed ID: 10984014
[TBL] [Abstract][Full Text] [Related]
8. Erdosteine.
Dechant KL; Noble S
Drugs; 1996 Dec; 52(6):875-81; discussion 882. PubMed ID: 8957158
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial.
Dal Negro RW; Visconti M; Turco P
Pulm Pharmacol Ther; 2015 Aug; 33():47-51. PubMed ID: 26116425
[TBL] [Abstract][Full Text] [Related]
10. Clinical effects of erdosteine in the treatment of acute respiratory tract diseases in children.
Balli F; Bergamini B; Calistru P; Ciofu EP; Domenici R; Doros G; Dragomir D; Gherghina I; Iordachescu F; Murgoci G; Orasanu D; Plesca D; Vaccaro A; Assereto R
Int J Clin Pharmacol Ther; 2007 Jan; 45(1):16-22. PubMed ID: 17256446
[TBL] [Abstract][Full Text] [Related]
11. The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data.
Cazzola M; Floriani I; Page CP
Pulm Pharmacol Ther; 2010 Apr; 23(2):135-44. PubMed ID: 19854285
[TBL] [Abstract][Full Text] [Related]
12. Combination Therapy with Budesonide and Salmeterol in Experimental Allergic Inflammation.
Pappová L; Jošková M; Kazimierová I; Šutovská M; Fraňová S
Adv Exp Med Biol; 2016; 935():25-34. PubMed ID: 27329088
[TBL] [Abstract][Full Text] [Related]
13. Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study.
Abut E; Yaşar B; Güveli H; Bölükbaş C; Bölükbaş FF; Dalay AR; Kurdaş OO
Scand J Gastroenterol; 2010 Jun; 45(6):677-83. PubMed ID: 20334478
[TBL] [Abstract][Full Text] [Related]
14. Erdosteine: Drug exhibiting polypharmacy for the treatment of respiratory diseases.
Dal Negro R; Pozzi E; Cella SG
Pulm Pharmacol Ther; 2018 Dec; 53():80-85. PubMed ID: 30352285
[TBL] [Abstract][Full Text] [Related]
15. The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough.
Makwana R; Venkatasamy R; Spina D; Page C
J Pharmacol Exp Ther; 2015 Apr; 353(1):169-80. PubMed ID: 25655949
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study.
Crisafulli E; Coletti O; Costi S; Zanasi E; Lorenzi C; Lucic S; Fabbri LM; Bertini M; Clini EM
Clin Ther; 2007 Sep; 29(9):2001-9. PubMed ID: 18035199
[TBL] [Abstract][Full Text] [Related]
17. Effect of erdosteine and its metabolites on tracheobronchial mucus production and transport.
Scuri R; Giannetti P; Paesano A
Drugs Exp Clin Res; 1988; 14(11):693-8. PubMed ID: 3246214
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effect of clenbuterol on citric acid-induced cough reflex in guinea pigs.
Horiuchi H; Nonaka T; Ito M; Kaniwa T; Kishimoto T; Fuchikami J; Kohjimoto Y; Kiyoki M
Res Commun Mol Pathol Pharmacol; 1995 Jun; 88(3):293-301. PubMed ID: 8564385
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin-induced acute renal failure is ameliorated by erdosteine in a dose-dependent manner.
Ozyurt H; Yildirim Z; Kotuk M; Yilmaz HR; Yağmurca M; Iraz M; Söğüt S; Gergerlioglu S
J Appl Toxicol; 2004; 24(4):269-75. PubMed ID: 15300714
[TBL] [Abstract][Full Text] [Related]
20. Effects of selective inhibition of PDE4 and PDE7 on airway reactivity and cough in healthy and ovalbumin-sensitized guinea pigs.
Mokry J; Joskova M; Mokra D; Christensen I; Nosalova G
Adv Exp Med Biol; 2013; 756():57-64. PubMed ID: 22836619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
